Literature DB >> 2863007

The quantitative analysis and stability of histochemical markers of altered hepatic foci in rat liver following initiation by diethylnitrosamine administration and promotion with phenobarbital.

T L Goldsworthy, H C Pitot.   

Abstract

The stability and response of histochemical phenotypes of altered hepatic foci (AHF) were studied both in the presence and following the withdrawal of 0.05% phenobarbital (PB) treatment in rats previously given a single dose of diethylnitrosamine (DEN) 20-24 h following partial hepatectomy (PH). AHF were scored by their expression of three biochemical markers: gamma-glutamyl transpeptidase (GGT), adenosine triphosphatase and glucose-6-phosphatase (G6P). AHF demonstrated significant heterogeneity with respect to the marker alterations. The use of three markers in the present study confirmed the findings of our earlier study, which showed the maximal response of GGT+ AHF to PB administration following PH/DEN initiation and the stability of GGT+/AHF induced by the PH/DEN/PB regimen after the withdrawal of PB. In the regimen employed, the GGT marker alone scored the great majority of the AHF detected by all three markers. The frequency distribution of histochemical phenotypes remained relatively constant in AHF during continuous PB administration and in AHF promoted by PB followed by a 6-month period of feeding a diet containing no PB. These findings suggest that individual AHF remain phenotypically stable throughout the PB promotion phase, i.e., do not progress from one phenotype to another. In every marker class, the mean volume of AHF increased during continuous PB administration. These data illustrate the enhancing effect of PB on the growth of the AHF. The size of AHF continued to increase following the withdrawal of PB in the 3-month PB treatment group, but not in the animals treated for 4 months. A mechanism that may account for the differences in these two treatment groups is discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2863007     DOI: 10.1093/carcin/6.9.1261

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  7 in total

Review 1.  Stage-specific gene expression during hepatocarcinogenesis in the rat.

Authors:  H C Pitot
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

2.  1alpha, 25-dihydroxyvitamin D3 prevents DNA damage and restores antioxidant enzymes in rat hepatocarcinogenesis induced by diethylnitrosamine and promoted by phenobarbital.

Authors:  Mahendrakumar Chandrasekharappa Banakar; Suresh Kanna Paramasivan; Mitali Basu Chattopadhyay; Subrata Datta; Prabir Chakraborty; Malay Chatterjee; Kalaiselvi Kannan; Elayaraja Thygarajan
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

3.  Dietary effects on initiation and promotion of hepatocarcinogenesis in rat.

Authors:  S Hendrich; H P Glauert; H C Pitot
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

4.  Induction and promotion of gamma-glutamyltranspeptidase-positive foci in the rat liver by methylglyoxal.

Authors:  A Martelli; M Ghia; E Mereto; U M Marinari; G Brambilla
Journal:  Jpn J Cancer Res       Date:  1988-06

5.  Dose response for TCDD promotion of hepatocarcinogenesis in rats initiated with DEN: histologic, biochemical, and cell proliferation endpoints.

Authors:  R R Maronpot; J F Foley; K Takahashi; T Goldsworthy; G Clark; A Tritscher; C Portier; G Lucier
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

6.  Quantitative comparison of initiation and mutation phenotypes in hepatocytes of the analbuminemic rat.

Authors:  Y P Dragan; C Laufer; A J Koleske; N Drinkwater; H C Pitot
Journal:  Jpn J Cancer Res       Date:  1993-02

Review 7.  Glutathione S-transferases and hepatocarcinogenesis.

Authors:  K Sato
Journal:  Jpn J Cancer Res       Date:  1988-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.